Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling

[1]  S. Elowe,et al.  Playing polo during mitosis: PLK1 takes the lead , 2017, Oncogene.

[2]  Chengwei He,et al.  Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review. , 2017, The American journal of Chinese medicine.

[3]  N. Ahmad,et al.  Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics , 2016, Molecular Cancer Therapeutics.

[4]  Osamu Kikuchi,et al.  Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. , 2015, Gastroenterology.

[5]  Q. Shi,et al.  Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression. , 2015, Journal of pharmacological sciences.

[6]  Shufeng Zhou,et al.  Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells , 2015, Drug design, development and therapy.

[7]  Shufeng Zhou,et al.  Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells , 2015, Drug design, development and therapy.

[8]  Wanqing Chen,et al.  Cancer statistics: updated cancer burden in China. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[9]  W. Zhong,et al.  Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCϵ, Stat3, and Epithelial-to-Mesenchymal Transition Markers , 2015, Cancer Prevention Research.

[10]  Zhe Zhang,et al.  Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer. , 2014, Cancer research.

[11]  J. Li,et al.  Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State , 2014, Molecular and Cellular Biology.

[12]  W. Duan,et al.  Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. , 2014, Cancer letters.

[13]  Shadma Parveen,et al.  Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches , 2014, PloS one.

[14]  H. Qiao,et al.  Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions , 2013, Bone Research.

[15]  H. Hong,et al.  Plumbagin, a medicinal plant (lumbago zeylanica)‐derived 1,4‐naphthoquinone, inhibits growth and metastasis of human prostate cancer PC‐3M‐luciferase cells in an orthotopic xenograft mouse model , 2013, Molecular oncology.

[16]  Yingsong 櫻松 Lin 林,et al.  Epidemiology of Esophageal Cancer in Japan and China , 2013, Journal of epidemiology.

[17]  D. Mukhopadhyay,et al.  Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo , 2013, International journal of cancer.

[18]  A. Verma,et al.  Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF‐κB signaling pathways , 2012, International journal of cancer.

[19]  Q. Zhan,et al.  Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. , 2012, Gastroenterology.

[20]  Mingyao Liu,et al.  Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor‐2 , 2012, British journal of pharmacology.

[21]  B. Aggarwal,et al.  Plumbagin Inhibits Osteoclastogenesis and Reduces Human Breast Cancer-Induced Osteolytic Bone Metastasis in Mice through Suppression of RANKL Signaling , 2011, Molecular Cancer Therapeutics.

[22]  G. Sethi,et al.  Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4 , 2011, Molecular Cancer.

[23]  G. Srinivasan,et al.  Apoptosis Inducing Effect of Plumbagin on Colonic Cancer Cells Depends on Expression of COX-2 , 2011, PloS one.

[24]  K. Strebhardt,et al.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy , 2010, Nature Reviews Drug Discovery.

[25]  A. Ray,et al.  Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics , 2010, Expert opinion on investigational drugs.

[26]  G. Adolf,et al.  BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity , 2009, Clinical Cancer Research.

[27]  David M. Glover,et al.  Polo-like kinases: conservation and divergence in their functions and regulation , 2009, Nature Reviews Molecular Cell Biology.

[28]  Xin Xu,et al.  Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma , 2009, International journal of cancer.

[29]  M. Aziz,et al.  Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. , 2008, Cancer research.

[30]  Shivendra V. Singh,et al.  Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species , 2008, Pharmaceutical Research.

[31]  Péter Lénárt,et al.  BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo , 2007, Current Biology.

[32]  P. Kuo,et al.  Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells , 2006, Molecular Cancer Therapeutics.

[33]  P. Kuo,et al.  Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells through p53 Accumulation via c-Jun NH2-Terminal Kinase-Mediated Phosphorylation at Serine 15 in Vitro and in Vivo , 2006, Journal of Pharmacology and Experimental Therapeutics.

[34]  Xiaoqi Liu,et al.  Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[36]  汤亭亭.  Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions , 2013 .

[37]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[38]  Robert C. Wolpert,et al.  A Review of the , 1985 .